Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3770)
All Articles published online
|
Nov 1, 2004 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yu JK, Chen YD, Zheng S. An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. World J Gastroenterol 2004; 10(21): 3127-3131 [PMID: 15457557 DOI: 10.3748/wjg.v10.i21.3127] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i21/3127.htm |
| Number | Citing Articles |
| 1 |
Jose L. Luque-Garcia, Thomas A. Neubert. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry. Journal of Chromatography A 2007; 1153(1-2): 259 doi: 10.1016/j.chroma.2006.11.054
|
| 2 |
Jens K. Habermann, Franz G. Bader, Christian Franke, Kaja Zimmermann, Timo Gemoll, Britta Fritzsche, Thomas Ried, Gert Auer, Hans-Peter Bruch, Uwe J. Roblick. From the genome to the proteome—biomarkers in colorectal cancer. Langenbeck's Archives of Surgery 2007; 393(1): 93 doi: 10.1007/s00423-007-0230-1
|
| 3 |
Kenneth E. Hung, Daniel C. Chung. Colorectal Cancer Screening: Today and Tomorrow. Southern Medical Journal 2006; 99(3): 240 doi: 10.1097/01.smj.0000203817.89741.29
|
| 4 |
Hong He, Gang Sun, Feiyun Ping, Yanqing Cong. A New and Preliminary Three-dimensional Perspective: Proteomes of Optimization between OSCC and OLK. Artificial Cells, Blood Substitutes, and Biotechnology 2011; 39(1): 26 doi: 10.3109/10731199.2010.516258
|
| 5 |
Y.-W. LIN, H.-C. LAI, C.-Y. LIN, J.-Y. CHIOU, H.-A. SHUI, C.-C. CHANG, M.-H. YU, T.-Y. CHU. Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix. International Journal of Gynecological Cancer 2006; 16(3): 1216 doi: 10.1111/j.1525-1438.2006.00583.x
|
| 6 |
Keishi Yamashita, Masahiko Watanabe. Clinical significance of tumor markers and an emerging perspective on colorectal cancer. Cancer Science 2009; 100(2): 195 doi: 10.1111/j.1349-7006.2008.01022.x
|
| 7 |
Y.W. Lin, H.C. Lai, C.Y. Lin, J.Y. Chiou, H.A. Shui, C.C. Chang, M.H. Yu, T.Y. Chu. Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix. International Journal of Gynecological Cancer 2006; 16(3): 1216 doi: 10.1136/ijgc-00009577-200605000-00041
|
| 8 |
Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer. PROTEOMICS – Clinical Applications 2012; 6(3-4): 182 doi: 10.1002/prca.201100095
|
| 9 |
Eric T Fung, Scot R Weinberger, Ed Gavin, Fujun Zhang. Bioinformatics approaches in clinical proteomics. Expert Review of Proteomics 2005; 2(6): 847 doi: 10.1586/14789450.2.6.847
|
| 10 |
Xiao-hui Zhai, Jie-kai Yu, Chen Lin, Li-dong Wang, Shu Zheng. Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesion. Journal of Zhejiang University SCIENCE B 2012; 13(12): 964 doi: 10.1631/jzus.B1200066
|
| 11 |
D G Ward, N Suggett, Y Cheng, W Wei, H Johnson, L J Billingham, T Ismail, M J O Wakelam, P J Johnson, A Martin. Identification of serum biomarkers for colon cancer by proteomic analysis. British Journal of Cancer 2006; 94(12): 1898 doi: 10.1038/sj.bjc.6603188
|
| 12 |
Sabrina Hundt, Ulrike Haug, Hermann Brenner. Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review. Cancer Epidemiology, Biomarkers & Prevention 2007; 16(10): 1935 doi: 10.1158/1055-9965.EPI-06-0994
|
| 13 |
Y.-W Lin, C.-Y Lin, H.-C Lai, J.-Y Chiou, C.-C Chang, M.-H Yu, T.-Y Chu. Plasma proteomic pattern as biomarkers for ovarian cancer. International Journal of Gynecological Cancer 2006; 16: 139 doi: 10.1136/ijgc-00009577-200602001-00023
|
| 14 |
F.M. Smith, J.V. Reynolds, N. Miller, R.B. Stephens, M.J. Kennedy. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. European Journal of Surgical Oncology (EJSO) 2006; 32(1): 55 doi: 10.1016/j.ejso.2005.09.010
|
| 15 |
Fraser M. Smith, William M. Gallagher, Edward Fox, Richard B. Stephens, Elton Rexhepaj, Emanuel F. Petricoin, Lance Liotta, M John Kennedy, John V. Reynolds. Combination of SELDI-TOF-MS and Data Mining Provides Early-stage Response Prediction for Rectal Tumors Undergoing Multimodal Neoadjuvant Therapy. Annals of Surgery 2007; 245(2): 259 doi: 10.1097/01.sla.0000245577.68151.bd
|
| 16 |
Judith Y M N Engwegen, Niven Mehra, John B A G Haanen, Johannes M G Bonfrer, Jan H M Schellens, Emile E Voest, Jos H Beijnen. Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations. Laboratory Investigation 2007; 87(2): 161 doi: 10.1038/labinvest.3700503
|
| 17 |
Y.-W. LIN, C.-Y. LIN, H.-C. LAI, J.-Y. CHIOU, C.-C. CHANG, M.-H. YU, T.-Y. CHU. Plasma proteomic pattern as biomarkers for ovarian cancer. International Journal of Gynecological Cancer 2006; 16(S1): 139 doi: 10.1111/j.1525-1438.2006.00475.x
|
| 18 |
Fu-Ming Qiu, Jie-Kai Yu, Yi-Ding Chen, Qi-Feng Jin, Mei-Hua Sui, Jian Huang. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. Journal of Experimental & Clinical Cancer Research 2009; 28(1) doi: 10.1186/1756-9966-28-126
|
| 19 |
Hui Meng, Wenxue Hong, Jialin Song, Liqiang Wang. Feature Extraction and Analysis of Ovarian Cancer Proteomic Mass Spectra. 2008 2nd International Conference on Bioinformatics and Biomedical Engineering 2008; : 668 doi: 10.1109/ICBBE.2008.163
|
| 20 |
Nishu Dalal, Rekha Jalandra, Minakshi Sharma, Hridayesh Prakash, Govind K. Makharia, Pratima R. Solanki, Rajeev Singh, Anil Kumar. Omics technologies for improved diagnosis and treatment of colorectal cancer: Technical advancement and major perspectives. Biomedicine & Pharmacotherapy 2020; 131: 110648 doi: 10.1016/j.biopha.2020.110648
|
| 21 |
Marie-Christine W. Gast, Carla H. van Gils, Lodewijk F.A. Wessels, Nathan Harris, Johannes M.G. Bonfrer, Emiel J.Th. Rutgers, Jan H.M. Schellens, Jos H. Beijnen. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS). Clinical Chemistry and Laboratory Medicine 2009; 47(6) doi: 10.1515/CCLM.2009.151
|
| 22 |
Eugenio Ragazzi, Salvatore Pucciarelli, Roberta Seraglia, Laura Molin, Marco Agostini, Mario Lise, Pietro Traldi, Donato Nitti. Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer. Journal of Mass Spectrometry 2006; 41(12): 1546 doi: 10.1002/jms.1113
|
| 23 |
Jia‐Xiang Wang, Jie‐kai Yu, Li Wang, Qiu‐Liang Liu, Jiao Zhang, Shu Zheng. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma. PROTEOMICS 2006; 6(19): 5344 doi: 10.1002/pmic.200500833
|
| 24 |
Magda Bakun, Jakub Karczmarski, Jaroslaw Poznanski, Tymon Rubel, Malgorzata Rozga, Agata Malinowska, Dorota Sands, Ewa Hennig, Janusz Oledzki, Jerzy Ostrowski, Michal Dadlez. An integrated LC‐ESI‐MS platform for quantitation of serum peptide ladders. Application for colon carcinoma study. PROTEOMICS – Clinical Applications 2009; 3(8): 932 doi: 10.1002/prca.200800111
|
| 25 |
Michael T. Davis, Paul Auger, Chris Spahr, Scott D. Patterson. Cancer biomarker discovery via low molecular weight serum proteome profiling – Where is the tumor?. PROTEOMICS – Clinical Applications 2007; 1(12): 1545 doi: 10.1002/prca.200700141
|
| 26 |
J. S. Yu, S. Ongarello, R. Fiedler, X. W. Chen, G. Toffolo, C. Cobelli, Z. Trajanoski. Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data. Bioinformatics 2005; 21(10): 2200 doi: 10.1093/bioinformatics/bti370
|
| 27 |
Ki Tae Suk. An "Omics" Based Survey of Human Colon Cancer (Proteomics). Intestinal Research 2011; 9(1): 66 doi: 10.5217/ir.2011.9.1.66
|
| 28 |
Edmond O'Riordan, Steven S Gross, Michael S Goligorsky. Technology Insight: renal proteomics—at the crossroads between promise and problems. Nature Clinical Practice Nephrology 2006; 2(8): 445 doi: 10.1038/ncpneph0241
|
| 29 |
M. Ventura, A. Sanchez-Niubo, F. Ruiz, N. Agell, R. Ventura, C. Angulo, A. Domingo-Salvany, J. Segura, R. de la Torre. Qualitative evaluation of chromatographic data from quality control schemes using a support vector machine. The Analyst 2008; 133(1): 105 doi: 10.1039/B711653P
|
| 30 |
Judith Y.M.N. Engwegen, Marie-Christine W. Gast, Jan H.M. Schellens, Jos H. Beijnen. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends in Pharmacological Sciences 2006; 27(5): 251 doi: 10.1016/j.tips.2006.03.003
|
| 31 |
Shahida Din, Anne Marie Lennon, Ian DR Arnott, Ted Hupp, Jack Satsangi. Technology Insight: the application of proteomics in gastrointestinal disease. Nature Clinical Practice Gastroenterology & Hepatology 2007; 4(7): 372 doi: 10.1038/ncpgasthep0872
|
| 32 |
Douglas G Ward, Stephen Nyangoma, Howard Joy, Emma Hamilton, Wenbin Wei, Chris Tselepis, Neil Steven, Michael JO Wakelam, Philip J Johnson, Tariq Ismail, Ashley Martin. Proteomic profiling of urine for the detection of colon cancer. Proteome Science 2008; 6(1) doi: 10.1186/1477-5956-6-19
|
| 33 |
Harold Tjalsma. Identification of biomarkers for colorectal cancer through proteomics-based approaches. Expert Review of Proteomics 2010; 7(6): 879 doi: 10.1586/epr.10.81
|
| 34 |
Nikhil Pawa, Tan Arulampalam, John D. Norton. Screening for colorectal cancer: established and emerging modalities. Nature Reviews Gastroenterology & Hepatology 2011; 8(12): 711 doi: 10.1038/nrgastro.2011.205
|
| 35 |
Anouck Huijbers, Berit Velstra, Tim J. A. Dekker, Wilma E. Mesker, Yuri E. M. van der Burgt, Bart J. Mertens, André M. Deelder, Rob A. E. M. Tollenaar. Proteomic Serum Biomarkers and Their Potential Application in Cancer Screening Programs. International Journal of Molecular Sciences 2010; 11(11): 4175 doi: 10.3390/ijms11114175
|
| 36 |
ME de Noo, RAEM Tollenaar, AM Deelder, LH Bouwman. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: Hopes and fears. World Journal of Gastroenterology 2006; 12(41): 6594-6601 doi: 10.3748/wjg.v12.i41.6594
|
| 37 |
Anita R Skandarajah, Robert L Moritz, Joe J Tjandra, Richard J Simpson. Proteomic analysis of colorectal cancer: discovering novel biomarkers. Expert Review of Proteomics 2005; 2(5): 681 doi: 10.1586/14789450.2.5.681
|
| 38 |
Arunava Sankar Nath, Aparajita Pal, Somnath Mukhopadhyay, Kartick Chandra Mondal. A survey on cancer prediction and detection with data analysis. Innovations in Systems and Software Engineering 2020; 16(3-4): 231 doi: 10.1007/s11334-019-00350-6
|
| 39 |
Thomas Göbel, Sonja Vorderwülbecke, Katarzyna Hauck, Holger Fey, Dieter Häussinger, Andreas Erhardt. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples. World Journal of Gastroenterology 2006; 12(47): 7604-7612 doi: 10.3748/wjg.v12.i47.7604
|
| 40 |
David F. Ransohoff, Christopher Martin, Wesley S. Wiggins, Ben A. Hitt, Temitope O. Keku, Joseph A. Galanko, Robert S. Sandler. Assessment of Serum Proteomics to Detect Large Colon Adenomas. Cancer Epidemiology, Biomarkers & Prevention 2008; 17(8): 2188 doi: 10.1158/1055-9965.EPI-07-2767
|
| 41 |
Judith Y.M.N. Engwegen, Annekatrien C.T.M. Depla, Marianne E. Smits, Annemieke Cats, Henriëtte Tuynman, Henk A. Van Heukelem, Pleun Snel, Wouter Meuleman, Lodewyk F. Wessels, Jan H.M. Schellens, Jos H. Beijnen. Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk. Biomarker Insights 2008; 3: BMI.S790 doi: 10.4137/BMI.S790
|
| 42 |
Jennifer Colangelo, Michael Lawton, William Pennie. Surrogate Tissue Analysis. 2005; : 275 doi: 10.1201/9781420038095.ch17
|
| 43 |
Shao-Pai Wu, Ya-Wen Lin, Hung-Cheng Lai, Tang-Yuan Chu, Yu-Liang Kuo, Hang-Seng Liu. Seldi-tof MS Profiling of Plasma Proteins in Ovarian Cancer. Taiwanese Journal of Obstetrics and Gynecology 2006; 45(1): 26 doi: 10.1016/S1028-4559(09)60186-8
|
| 44 |
Grania Christyani, Matthew Carswell, Sisi Qin, Wootae Kim. An Overview of Advances in Rare Cancer Diagnosis and Treatment. International Journal of Molecular Sciences 2024; 25(2): 1201 doi: 10.3390/ijms25021201
|
| 45 |
N.A. Henderson, R.J.C. Steele. SELDI-TOF proteomic analysis and cancer detection. The Surgeon 2005; 3(6): 383 doi: 10.1016/S1479-666X(05)80048-4
|
| 46 |
Bilal Alaiyan, Nadia Ilyayev, Alexander Stojadinovic, Mina Izadjoo, Marina Roistacher, Vera Pavlov, Victoria Tzivin, David Halle, Honguang Pan, Barry Trink, Ali O Gure, Aviram Nissan. Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-196
|
| 47 |
Erika Hissong, Meredith E. Pittman. Colorectal carcinoma screening: Established methods and emerging technology. Critical Reviews in Clinical Laboratory Sciences 2020; 57(1): 22 doi: 10.1080/10408363.2019.1670614
|
| 48 |
Carol R. Regueiro. AGA Future Trends Committee Report: Colorectal Cancer: A Qualitative Review of Emerging Screening and Diagnostic Technologies. Gastroenterology 2005; 129(3): 1083 doi: 10.1053/j.gastro.2005.06.012
|
| 49 |
Wenxue Hong, Hui Meng, Liqiang Wang, Jialin Song. Advanced Intelligent Computing Theories and Applications. With Aspects of Theoretical and Methodological Issues. Lecture Notes in Computer Science 2007; 4681: 1231 doi: 10.1007/978-3-540-74171-8_125
|
| 50 |
Biomarker Signature Discovery from Mass Spectrometry Data. IEEE/ACM Transactions on Computational Biology and Bioinformatics 2014; 11(4): 766 doi: 10.1109/TCBB.2014.2318718
|
| 51 |
Peter Findeisen, Michael Neumaier. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective. Clinical Chemistry and Laboratory Medicine 2009; 47(6) doi: 10.1515/CCLM.2009.159
|
| 52 |
Eline Berghmans, Kurt Boonen, Evelyne Maes, Inge Mertens, Patrick Pauwels, Geert Baggerman. Implementation of MALDI Mass Spectrometry Imaging in Cancer Proteomics Research: Applications and Challenges. Journal of Personalized Medicine 2020; 10(2): 54 doi: 10.3390/jpm10020054
|
| 53 |
Judith YMN Engwegen, Helgi H Helgason, Annemieke Cats, Nathan Harris, Johannes MG Bonfrer, Jan HM Schellens, Jos H Beijnen. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World Journal of Gastroenterology 2006; 12(10): 1536-1544 doi: 10.3748/wjg.v12.i10.1536
|
| 54 |
Zhihao Xing, Chen Chu, Lei Chen, Xiangyin Kong. The use of Gene Ontology terms and KEGG pathways for analysis and prediction of oncogenes. Biochimica et Biophysica Acta (BBA) - General Subjects 2016; 1860(11): 2725 doi: 10.1016/j.bbagen.2016.01.012
|
| 55 |
Shen Hu, Joseph A. Loo, David T. Wong. Human body fluid proteome analysis. PROTEOMICS 2006; 6(23): 6326 doi: 10.1002/pmic.200600284
|
| 56 |
Hao Wang, Chenghua Luo, Shengtao Zhu, Honghong Fang, Qing Gao, Siqi Ge, Haixia Qu, Qingwei Ma, Hongwei Ren, Youxin Wang, Wei Wang. Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts. Oncotarget 2017; 8(35): 59376 doi: 10.18632/oncotarget.19587
|
| 57 |
Mirre E. de Noo, Bart J.A. Mertens, Aliye Özalp, Marco R. Bladergroen, Martijn P.J. van der Werff, Cornelis J.H. van de Velde, Andre M. Deelder, Rob A.E.M. Tollenaar. Detection of colorectal cancer using MALDI-TOF serum protein profiling. European Journal of Cancer 2006; 42(8): 1068 doi: 10.1016/j.ejca.2005.12.023
|
| 58 |
Kwasi Antwi, Galen Hostetter, Michael J. Demeure, Benjamin A. Katchman, G. Anton Decker, Yvette Ruiz, Timothy D. Sielaff, Lawrence J. Koep, Douglas F. Lake. Analysis of the Plasma Peptidome from Pancreas Cancer Patients Connects a Peptide in Plasma to Overexpression of the Parent Protein in Tumors. Journal of Proteome Research 2009; 8(10): 4722 doi: 10.1021/pr900414f
|
| 59 |
Nicholas P. Munro, David A. Cairns, Paul Clarke, Mark Rogers, Anthea J. Stanley, Jennifer H. Barrett, Patricia Harnden, Douglas Thompson, Ian Eardley, Rosamonde E. Banks, Margaret A. Knowles. Urinary biomarker profiling in transitional cell carcinoma. International Journal of Cancer 2006; 119(11): 2642 doi: 10.1002/ijc.22238
|
| 60 |
Abdo Meyiah, Faez Iqbal Khan, Dia Aldeen Alfaki, Khaled Murshed, Afsheen Raza, Eyad Elkord. The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy. Translational Oncology 2025; 53: 102307 doi: 10.1016/j.tranon.2025.102307
|
| 61 |
XIAO-HUI ZHAI, JIE-KAI YU, FU-QUAN YANG, SHU ZHENG. Identification of a new protein biomarker for colorectal cancer diagnosis. Molecular Medicine Reports 2012; 6(2): 444 doi: 10.3892/mmr.2012.923
|
| 62 |
Abedalrhman Alkhateeb, Ashraf Abou Tabl, Luis Rueda. Deep Learning for Biomedical Data Analysis. 2021; : 255 doi: 10.1007/978-3-030-71676-9_11
|